aTyr Pharma, Inc. (ATYR) vs Quantum Biopharma Ltd. (QNTM)

aTyr Pharma, Inc. and Quantum Biopharma Ltd. are both Biotechnology companies. aTyr Pharma, Inc. and Quantum Biopharma Ltd. are of similar size ($31.4M and $30.9M). Across the 12 metrics below, aTyr Pharma, Inc. leads on 7 and Quantum Biopharma Ltd. on 5.

Valuation

Metric ATYR QNTM Biotechnology median
P/E n/m n/m 7.88
P/S 2.64 110.47 11.47
P/B 0.61 4.20 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA 0.42 n/m 0.74
EV/Sales (2.39) 68.43 10.73
Earnings yield (206.67%) (142.60%) (28.84%)
Free cash flow yield (186.29%) (35.37%) (23.03%)

Profitability

Metric ATYR QNTM Biotechnology median
Gross margin 1.72% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (98.67%) (618.06%) (57.72%)
Return on assets (70.97%) (169.48%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ATYR QNTM Biotechnology median
Revenue growth (TTM) 6.78% — 5.64%
EPS growth (last fiscal year) 6.98% 37.50% —
Revenue growth, 5-year CAGR (14.75%) — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ATYR QNTM Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 5.12 1.20 4.73
Net debt to EBITDA 1.01 0.31 0.96

Dividend

Metric ATYR QNTM Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric ATYR QNTM Biotechnology median
Market cap 31.38m 30.89m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack